Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Raballo

Showing results (61-70 of 221) with videos related to

Pageof 23
Sort By:
Early Intervention in Psychiatry|April 8, 2024
PSYCHS: Bridging Positive Symptoms and Diagnostic Criteria for Clinical High Risk for Psychosis-A litmus test for the fieldAndrea Raballo, Michele Poletti, Antonio Preti
Applied Neuropsychology. Child|July 19, 2019
Developmental dynamic interplay between executive functions and psychotic riskMichele Poletti, Eva Gebhardt, Andrea Raballo
Journal of Affective Disorders|May 3, 2006
Typus melancholicus: personality structure and the characteristics of major unipolar depressive episodeGiovanni Stanghellini, Marco Bertelli, Andrea Raballo
JAMA Psychiatry|October 5, 2017
Corollary Discharge, Self-agency, and the Neurodevelopment of the Psychotic MindMichele Poletti, Eva Gebhardt, Andrea Raballo
Frontiers in Public Health|May 26, 2022
Vaccine Hesitancy, Anti-Vax, COVID-Conspirationism: From Subcultural Convergence to Public Health and Bioethical ProblemsAndrea Raballo, Michele Poletti, Antonio Preti
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 3, 2019
Impaired Corollary Discharge in Psychosis and At-Risk States: Integrating Neurodevelopmental, Phenomenological, and Clinical PerspectivesMichele Poletti, Alfonso Tortorella, Andrea Raballo
CNS Spectrums|May 24, 2021
Along the fringes of Agency: neurodevelopmental account of the obsessive mindMichele Poletti, Eva Gebhardt, Andrea Raballo
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 22, 2025
Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysisAndrea Raballo, Michele Poletti, Antonio Preti
JAMA Psychiatry|March 20, 2024
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-AnalysisAndrea Raballo, Michele Poletti, Antonio Preti
Schizophrenia Research|March 26, 2026
Duration of Active Attenuated Psychosis (DAAP): Extending time-based illness modelling to the clinical high-risk stateMichele Poletti, Antonio Preti, Andrea Raballo
Pageof 23

Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
Early Intervention in Psychiatry|April 8, 2024
PSYCHS: Bridging Positive Symptoms and Diagnostic Criteria for Clinical High Risk for Psychosis-A litmus test for the fieldAndrea Raballo, Michele Poletti, Antonio Preti
Applied Neuropsychology. Child|July 19, 2019
Developmental dynamic interplay between executive functions and psychotic riskMichele Poletti, Eva Gebhardt, Andrea Raballo
Journal of Affective Disorders|May 3, 2006
Typus melancholicus: personality structure and the characteristics of major unipolar depressive episodeGiovanni Stanghellini, Marco Bertelli, Andrea Raballo
JAMA Psychiatry|October 5, 2017
Corollary Discharge, Self-agency, and the Neurodevelopment of the Psychotic MindMichele Poletti, Eva Gebhardt, Andrea Raballo
Frontiers in Public Health|May 26, 2022
Vaccine Hesitancy, Anti-Vax, COVID-Conspirationism: From Subcultural Convergence to Public Health and Bioethical ProblemsAndrea Raballo, Michele Poletti, Antonio Preti
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 3, 2019
Impaired Corollary Discharge in Psychosis and At-Risk States: Integrating Neurodevelopmental, Phenomenological, and Clinical PerspectivesMichele Poletti, Alfonso Tortorella, Andrea Raballo
CNS Spectrums|May 24, 2021
Along the fringes of Agency: neurodevelopmental account of the obsessive mindMichele Poletti, Eva Gebhardt, Andrea Raballo
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 22, 2025
Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysisAndrea Raballo, Michele Poletti, Antonio Preti
JAMA Psychiatry|March 20, 2024
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-AnalysisAndrea Raballo, Michele Poletti, Antonio Preti
Schizophrenia Research|March 26, 2026
Duration of Active Attenuated Psychosis (DAAP): Extending time-based illness modelling to the clinical high-risk stateMichele Poletti, Antonio Preti, Andrea Raballo
Pageof 23